AG003CY2

70024-40-7 | Terazosin hydrochloride dihydrate

AG003CY2

SDS

COA

Price

$0.00

WARNING This product is not for human or veterinary use.

CAS Number	70024-40-7
Catalog Number	AG003CY2(AGN-PC-0TXIWQ)
Chemical Name	Terazosin hydrochloride dihydrate
IUPAC Name	[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;dihydrate;hydrochloride
InChI	InChI=1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2
InChI Key	NZMOFYDMGFQZLS-UHFFFAOYSA-N
MDL Number	MFCD00941408
Molecular Formula	C19H30ClN5O6
Molecular Weight	459.9244
SMILES	O=C(C1OCCC1)N2CCN(CC2)C3=NC(N)=C4C=C(C(OC)=CC4=N3)OC.[H]Cl.[H]O[H].[H]O[H]
Synonyms	A 45975, Adecur, Apo-Terazosin, Deflox, Dysalfa, Flotrin, Heitrin, Hytrin, Hytrin BPH, Hytrine, Magnurol, Novo-Terazosin, Nu-Terazosin, PMS-Terazosin, ratio-Terazosin, Sutif, Tazusin, Terazoflo, terazosin, Terazosin AZU, Terazosin Hexal, Terazosin hydrochloride, terazosin hydrochloride anhydrous, terazosin, monohydrochloride, dihydrate, Terazosina Alter, Terazosina Kern, Terazosina Qualix, Zayasel, Terazosin hydrochloride dihydrate, 70024-40-7, Magnurol, Terazosin HCl, Dysalfa, Flotrin, Heitrin, Hytrine, Terazosin HCl dihydrate, Adecur, Deflox, Urodie, Hytrin, Hydracin, Hytrinex, Isontyn, Sinalfa, Teralfa, Teraprost, Unoprost, Hitrin, Uroflo, Vicard, Itrin, Terazosin Abbot, Terazosin monohydrochloride dihydrate, Abbott-45975, Terazosin (hydrochloride dihydrate), Hytracin, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine monohydrochloride dihydrate, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine HCl 2H2O, A-45975, Terazosin hydrochloride dihydrate, 98%, Hytrin BPH, (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone hydrochloride dihydrate, [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone dihydrate hydrochloride, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride, dihydrate, Dysalfa dihydrate, Flotrin dihydrate, Heitrin dihydrate, [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;dihydrate;hydrochloride, Terazosin Hydrochloride [USAN:JAN], Hytrin (TN), MFCD00941408, Terazosin monohydrochloride dihydrate, PubChem2386, Terazosin hydrochloride [USAN:USP:JAN], Terazosin HCl (Hytrin), AC1L1Y7M, C19H30ClN5O6, Terazosin hydrochloride (USAN), methanone hydrochloride dihydrate, CHEMBL3989562, CTK8B3512, HY-B0371A, ABT-975, NZMOFYDMGFQZLS-UHFFFAOYSA-N, C19H25N5O4.2H2O.HCl, BCP12141, ANW-42643, MY-208, RW2755, s2059, Terazosin hydrochloride dihydrate,(S), AKOS015962345, Terazosin hydrochloride hydrate (JAN), AC-8239, AN-8176, API0024686, CS-2428, KS-1119, piperazin-1-yl)(tetrahydrofuran-2-yl), VA11841, KS-00000H42, terazosine, monohydrochloride, dihydrate, AK307581, H977, AB0013399, LS-110236, TL8004378, FT-0630794, SW196457-4, D00610, 024T407, A836740, C-22590, Terazosin hydrochloride, United States Pharmacopeia (USP) Reference Standard, Terazosin for system suitability, European Pharmacopoeia (EP) Reference Standard, Terazosin hydrochloride dihydrate, European Pharmacopoeia (EP) Reference Standard, Terazosin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-(2-oxolanyl)methanone dihydrate hydrochloride, [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone dihydrate hydrochloride, [4-(4-azanyl-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone dihydrate hydrochloride, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furanyl-)carbonyl)-piperazine hydrochloride dihydrate, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-,monohydrochloride, dihydrate, Terazosin hydrochloride, Zayasel, terazosin, Terazoflo, Vasocard, Tazusin, Vasomet, Sutif, ratio-Terazosin, Terazosin Hexal, Terazosina Kern, Novo-Terazosin, Apo-Terazosin, Nu-Terazosin, Terazosina Alter, PMS-Terazosin, Terazosin AZU, Terazosina Qualix, UNII-D32S14F082, Terazosin hydrochloride anhydrous, C19H25N5O4.ClH.2H2O, CID63016, terazosin, monohydrochloride, dihydrate, CS-O-05309, D32S14F082, C19-H25-N5-O4.Cl-H.2H2-O, 1602H, (4-(4-amino-6,7-dimethoxyquinazolin-2-yl), A 45975, C041226, 4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride, 63590-64-7,

Complexity	544
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	4
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	459.188g/mol
Formal Charge	0
Heavy Atom Count	31
Hydrogen Bond Acceptor Count	10
Hydrogen Bond Donor Count	4
Isotope Atom Count	0
Molecular Weight	459.928g/mol
Monoisotopic Mass	459.188g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	105A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
Signal Words	warning
UN Code

Certificate of Analysis

Lot Number